Please login to the form below

Not currently logged in
Email:
Password:

Lilly launches diabetes partnership programme in South Africa

Partners with Project Hope and Donald Woods Foundation

Lilly has extended its non-communicable diseases (NCD) partnership programme to South Africa, where it has joined with Project Hope and Donald Woods Foundation (DWF) to help tackle the rise in diabetes.

The Lilly NCD Partnership programme was set up in 2011, with an investment of US$30m over five years. The aim of the partnerships has been to develop new approaches to managing NCDs, such as diabetes, cancer and heart disease, in the developing world.

South Africa is expected to experience the highest growth rate of diabetes in the world over the next 20 years, according to Lilly's corporate communications director, corporate social responsibility, David Marbaugh.

“Ultimately, the goal of the Lilly NCD Partnership is to find new, cost-effective solutions that can be replicated and scaled up by governments around the world,” he said, writing on Lilly's corporate blog. “Our initial focus is on diabetes in disadvantaged communities in Brazil, India, Mexico, and South Africa.”

Part of this process will involve community outreach and support through preventative screening, diagnosis and treatment services, and health education programmes.

According to the World Health Organization (WHO), non-communicable diseases account for 63 per cent of global deaths and nearly 80 per cent of deaths in low- to middle-income countries.

WHO members last week agreed the first-ever global monitoring framework to combat NCDs like heart disease, diabetes, cancer and chronic lung disease with nine voluntary global targets and 25 indicators to help prevent and control them.

12th November 2012

From: Research, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics